Can diabetes drugs help Wolfram syndrome? A new study looks at real-world use.

When a rare genetic disease like Wolfram syndrome causes both diabetes and progressive vision loss, doctors and families are desperate for anything that might help. A new study looked at whether a popular class of diabetes drugs, called GLP-1 receptor agonists, is being used in this community and what happened. The researchers examined records for 84 people with genetically confirmed Wolfram syndrome and found that about 35% had been prescribed one of these drugs. The most common reason was to try to manage blood sugar, but the study found no statistically significant improvements in long-term blood sugar levels or body weight. Importantly, vision continued to decline over two years, which is consistent with the expected progression of the disease. Many people also stopped taking the drugs, often because of common side effects like nausea and other stomach issues. This was an observational look back at medical records, not a controlled trial designed to test if the drugs work for Wolfram syndrome. It tells us these medications are already in use, but we still need prospective studies to find out if they can truly modify the course of this challenging condition.